Clinical Trial Update: Study of Autologous Total Immunoglobulin G Therapy for Atopic Dermatitis [Phase 2, Phase 3]

View source ↗

Summary

The document notes completion of a Phase 2/Phase 3 clinical study evaluating autologous total immunoglobulin G therapy for atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Autologous total immunoglobulin G therapy

Snippet

Sponsor: Ajou University School of Medicine | Conditions: Dermatitis, Atopic | Phase 2, Phase 3 | Status: COMPLETED